It’s certainly going to be a rocking scene, in Negombo, on Saturday, 22nd November. In action at ‘Santana Bloom,’ to be held ...

On track to submit GraftAssureDx™ for FDA review by year-endOn track for commitment to have 20 transplant centers globally ...

Gevo reported a $3.7 million loss from operations for the three months ended September 30, 2025, and positive Adjusted EBITDA 1 of approximately $6.7 million for the three months ended September 30, ...

Mark R. Ludwikowski and Laura M. Quesada of Clark Hill PLC examine how new tariffs on trucks signal the evolution of Section 232 from a national security safeguard into a broader instrument of U.S.

H1-B visa reform is needed now. In the global race for chips and AI, the U.S. cannot continue treating this most important H1-B talent entry point like a lottery ticket.

Three research scientist entrepreneurs with roots in university labs and life sciences startup companies have announced ...

Q4 2025 Earnings Call November 10, 2025 9:00 AM ESTCompany ParticipantsJon KatholDonnie King - President, CEO & ...

INLIGHT is currently ongoing at multiple trial sites, including in the US following clearance of an Investigational New Drug (IND) application. Wave has expanded Cohort 2, Cohort 3, and Cohort 4 (600 ...

Cricket’s market(ing) power was never built on merit alone — it was built on belief. When we extend that belief to women ...

Q3 2025 Earnings Call November 10, 2025 8:30 AM ESTCompany ParticipantsKate Rausch - Head of Investor RelationsPaul Bolno ...

Billionaires are in fact bankrolling the far-right globally, a contradiction that must be exposed. It’s time to tax the super-rich. It’s time for every politician that says they are challenging the ...

Instead, the meeting confirmed the curious direction of U.S. China policy in Trump’s second term. The president has not only broken with the policy of the Biden administration but also seems to have ...